Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil

By Weycker Derek   Taneja Charu   Edelsberg John   Erder M. Haim   Schmitt Frederick A.   Setyawan Juliana   Oster Gerry  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1187-1197

Informa Healthcare

Access to resources Recommend Favorite

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis

By Farlow Martin R.   Alva Gus   Meng Xiangyi   Olin Jason T.  

Current Medical Research and Opinion, Vol. 26, Iss. 2, 2010-02 ,pp. : 263-269

Informa Healthcare

Access to resources Recommend Favorite

EFNS‐ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 19, Iss. 10, 2012-10 ,pp. : 1278-1291

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

By Choi Seong Hye   Park Kyung Won   Na Duk L.   Han Hyun Jeong   Kim Eun-Joo   Shim Yong S.   Lee Jae-Hong    

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1375-1383

Informa Healthcare

Access to resources Recommend Favorite

Depression and antidepressant use moderate association between widowhood and Alzheimer's disease

By  

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 30, Iss. 3, 2015-03 ,pp. : 292-299

John Wiley & Sons Inc

Access to resources Recommend Favorite